Difference between revisions of "Team:NCTU Formosa/Composite Part"

(Prototype team page)
 
 
(52 intermediate revisions by 5 users not shown)
Line 1: Line 1:
−
{{NCTU_Formosa}}
+
{{Team:NCTU_Formosa/navigation}}
 +
 
 
<html>
 
<html>
 +
<head>
 +
<style type=text/css>
 +
/* v1.0 | 20080212 */
  
−
<h2> Composite Parts</h2>
+
html, body, div, span, applet, object, iframe,
 +
h1, h2, h3, h4, h5, h6, p, blockquote, pre,
 +
a, abbr, acronym, address, big, cite, code,
 +
del, dfn, em, font, img, ins, kbd, q, s, samp,
 +
small, strike, strong, tt, var,
 +
b, u, i, center,
 +
dl, dt, dd, ol, ul, li,
 +
fieldset, form, label, legend,
 +
table, caption, tbody, tfoot, thead, tr, th, td {
 +
    margin: 0;
 +
    padding: 0;
 +
    border: 0;
 +
    outline: 0;
 +
    vertical-align: baseline;
 +
    background: transparent;
 +
}
 +
body {
 +
    line-height: 1;
 +
}
 +
ol, ul {
 +
    list-style: none;
 +
}
 +
blockquote, q {
 +
    quotes: none;
 +
}
 +
blockquote:before, blockquote:after,
 +
q:before, q:after {
 +
    content: '';
 +
    content: none;
 +
}
  
 +
/* remember to define focus styles! */
 +
:focus {
 +
    outline: 0;
 +
}
  
−
<div class="highlightBox">
+
/* remember to highlight inserts somehow! */
−
<h4>Note</h4>
+
ins {
−
<p>In order to be considered for the <a href="https://2015.igem.org/Judging/Awards#SpecialPrizes">Best New Composite Part award</a>, you must fill out this page. Please give links to the Registry entries for the Composite parts you have made. Please see the Registry's <a href="http://parts.igem.org/Help:Parts#Basic_and_Composite_Parts"> Help:Parts page</a> for more information on part types.</p>
+
    text-decoration: none;
 +
}
 +
 
 +
del {
 +
    text-decoration: line-through;
 +
}
 +
 
 +
/* tables still need 'cellspacing="0"' in the markup */
 +
table {
 +
    border-collapse: collapse;
 +
    border-spacing: 0;
 +
}
 +
.p01{
 +
background-color:#FF6347;
 +
position:relative;
 +
height:70vh;
 +
width:100%;
 +
left:0vw;
 +
opacity:0.8;
 +
}
 +
.p02{
 +
background-color:#FCFCDE;
 +
position:relative;
 +
width:100%;
 +
}
 +
.background1{
 +
background-image:url("https://static.igem.org/mediawiki/2015/d/dd/NCTU_Formosa_E.cotector4.png");
 +
background-repeat:no-repeat;
 +
background-position:center 12vh;
 +
position:relative;
 +
height:70vh;
 +
width:40vw;
 +
background-size:55%;
 +
top:0vh;
 +
left:10vw;
 +
opacity:0.9;
 +
float:left;
 +
}
 +
.title{
 +
font-family:Arial;
 +
font-size:33pt;
 +
position:relative;
 +
right:20vw;
 +
top:33vh;
 +
color:#fff;
 +
z-index:100;
 +
float:right;
 +
text-align:center;
 +
}
 +
.content{
 +
font-family:Arial;
 +
font-size:20pt;
 +
width:60vw;
 +
margin:0 auto;
 +
left:20vw;
 +
right:20vw;
 +
top:9vh;
 +
color:#000;
 +
text-align: justify;
 +
padding-top:6vh;
 +
padding-bottom:8vh;
 +
}
 +
.goto{
 +
position:relative;
 +
padding-left:20vw;
 +
padding-top:3vh;
 +
float:left;
 +
z-index:100;
 +
}
 +
.goto a{
 +
text-decoration:none;
 +
color:#000;
 +
}
 +
.goto1{
 +
position:relative;
 +
padding-left:76vw;
 +
padding-top:3vh;
 +
}
 +
.goto1 a{
 +
text-decoration:none;
 +
color:#000;
 +
}
 +
p{
 +
text-indent: 40px;
 +
font-family:Arial;
 +
font-size:14pt;
 +
position:relative;
 +
color:#000;
 +
text-align: justify;
 +
LINE-HEIGHT:25pt;
 +
}
 +
h1{
 +
font-size:25pt;
 +
}
 +
h2{
 +
font-size:20pt;
 +
padding-top:2vh;}
 +
table {
 +
  border:0;
 +
  border-collpase:collpase;
 +
}
 +
 
 +
td {
 +
padding-top:10px;
 +
  padding-bottom:50px;
 +
  text-align: left;
 +
  font-family:Arial;
 +
font-size:14pt;
 +
LINE-HEIGHT:25pt;
 +
}
 +
.part{
 +
font-size:16pt;
 +
}
 +
.part a{
 +
font-size:16pt;
 +
color:#0200FF;
 +
text-decoration:none;
 +
}
 +
.part span{font-size:18pt;}
 +
.reference{
 +
font-size:10pt;
 +
position:relative;
 +
border-top:#999 1px solid;
 +
}
 +
 
 +
 
 +
#groupparts {
 +
margin: 0 auto;
 +
background-color:#FCFCDE;}
 +
</style>
 +
 
 +
</head>
 +
<body>
 +
<div class="p01">
 +
<div class="background1"></div>
 +
<div class="title">Composite Parts</div>
 
</div>
 
</div>
 +
<div class="p02">
 +
<div class="content">
 +
<h2>Composite Part</h2>
  
−
<p>
+
<table>  
−
A composite part is a functional unit of DNA consisting of two or more basic parts assembled together. <a href="http://parts.igem.org/wiki/index.php/Part:BBa_I13507">BBa_I13507</a> is an example of a composite part, consisting of an RBS, a protein coding region for a red fluorescent protein, and a terminator.
+
  <tr><td width="20%"></td><td width="13%"></td><td width="67%"></td></tr>  
−
</p>
+
  
−
<p>New composite BioBrick devices can be made by combining existing BioBrick Parts (like Inverters, Amplifiers, Smell Generators, Protein Balloon Generators, Senders, Receivers, Actuators, and so on).</p>
+
  <tr><td class="part"><span><a href="http://parts.igem.org/Part:BBa_K1694013">BBa_K1694013</a></span><br>
 +
                                  OmpA-anti-VEGF<br>
 +
                      <span><a href="http://parts.igem.org/Part:BBa_K1694014">BBa_K1694014</a></span><br>
 +
                                OmpA-anti-EGFR<br>
 +
                      <span><a href="http://parts.igem.org/Part:BBa_K1694015">BBa_K1694015</a></span><br>
 +
                                OmpA-anti-HER2<br>
 +
</td><td></td><td>In order to change the scFv parts easily, we added a <i>Nco</i>I restriction site between OmpA and scFv so that we can change various scFv DNA sequence using the <i>Nco</i>I restriction enzyme.</td></tr>  
  
 +
<tr><td class="part"><span><a href="http://parts.igem.org/Part:BBa_K1694023">BBa_K1694023</a></span><br>
 +
                                  P<sub>cons</sub>+RBS+OmpA-anti-VEGF<br>
 +
                      <span><a href="http://parts.igem.org/Part:BBa_K1694024">BBa_K1694024</a></span><br>
 +
                                P<sub>cons</sub>+RBS+OmpA-anti-EGFR<br>
 +
                      <span><a href="http://parts.igem.org/Part:BBa_K1694025">BBa_K1694025</a></span><br>
 +
                                P<sub>cons</sub>+RBS+OmpA-anti-HER2<br>
 +
</td><td></td><td>By ligating the constitutive promoter (<a href="http://parts.igem.org/Part:BBa_J23101">BBa_J23101</a>), strong ribosome binding site (<a href="http://parts.igem.org/Part:BBa_B0034">BBa_B0034</a>) and Lpp-OmpA-scFv, we were able to display scFv on the <i>E.coli</i> outer membrane continuously.
 +
Having this part, we can co-transform with other parts in order to produce color as the detection signal.<br><br>
  
 +
In addition, by co-transforming these different types of <i>E.coli</i> with different fluorescence or color as signals, we are able to create a platform which can detect multimarker and consequently achieve combination therapy.
 +
</td></tr>
 +
 +
<tr><td class="part"><span><a href="http://parts.igem.org/Part:BBa_K1694033">BBa_K1694033</a></span><br>
 +
                                  P<sub>cons</sub>+RBS+OmpA-anti-VEGF+RBS+GFP+Ter<br>
 +
                      <span><a href="http://parts.igem.org/Part:BBa_K1694034">BBa_K1694034</a></span><br>
 +
                                P<sub>cons</sub>+RBS+OmpA-anti-EGFR+RBS+GFP+Ter<br>
 +
                      <span><a href="http://parts.igem.org/Part:BBa_K1694035">BBa_K1694035</a></span><br>
 +
                                P<sub>cons</sub>+RBS+OmpA-anti-HER2+RBS+GFP+Ter<br>
 +
                      <span><a href="http://parts.igem.org/Part:BBa_K1694044">BBa_K1694044</a></span><br>
 +
                      Pcons+RBS+OmpA-anti-EGFR+RBS+RFP+Ter<br>
 +
                      <span><a href="http://parts.igem.org/Part:BBa_K1694045">BBa_K1694045</a></span><br>
 +
                                P<sub>cons</sub>+RBS+OmpA-anti-HER2+RBS+BFP+Ter<br>
 +
                               
 +
</td><td></td><td>The most commonly constructing way of composite parts is to ligate the required parts together. We also provide this kind of parts.<br>
 +
At the back of the Lpp-OmpA-scFv part, we ligated the weaker ribosome biding site (<a href="網址">BBa_B0030</a>), different fluorescent protein and terminator (<a href="http://parts.igem.org/Part:BBa_J61048">BBa_J61048</a>) to make it continuously and simultaneously express the fluorescence and the scFv. We used a weak ribosome binding site to ensure that scFv's production will not be affected.
 +
</td></tr>
 +
 +
<tr><td class="part"><span><a href="http://parts.igem.org/Part:BBa_K1694053">BBa_K1694053</a></span><br>
 +
                                  P<sub>cons</sub>+RBS+OmpA-anti-VEGF+RBS+amilCP+Ter<br>
 +
                      <span><a href="http://parts.igem.org/Part:BBa_K1694054">BBa_K1694054</a></span><br>
 +
                                P<sub>cons</sub>+RBS+OmpA-anti-EGFR+RBS+amilCP+Ter<br>
 +
                      <span><a href="http://parts.igem.org/Part:BBa_K1694055">BBa_K1694055</a></span><br>
 +
                                P<sub>cons</sub>+RBS+OmpA-anti-HER2+RBS+amilCP+Ter<br>
 +
</td><td></td><td>Chromoprotein is another example of what can be added when making your own probe.<br>
 +
We constructed this part as the P<sub>cons</sub>+RBS+OmpA-scFv+RBS+fluorescent protein+Terminator part.
 +
</td></tr>
 +
 +
<tr><td class="part"><span><a href="http://parts.igem.org/Part:BBa_K1694027">BBa_K1694027</a></span><br>
 +
                                  P<sub>cons</sub>+RBS+FadL-GBP<br>
 +
</td><td></td><td>By ligating the induced promoter (<a href="http://parts.igem.org/Part:BBa_J23110">BBa_J23110</a>), ribosome binding site (<a href="http://parts.igem.org/Part:BBa_B0034">BBa_B0034</a>) and FadL-GBP, we can continuously display the GBP on the <i>E.coli</i> outer membrane.<br>
 +
Then we co-transform the OmpA-scFv parts and this FadL-GBP parts into the same <i>E.coli</i>, hence allowing our <i>E.coli</i> to bind on gold chips and detect antigens simultaneously.
 +
</td></tr>
 +
 +
<tr><td class="part"><span><a href="http://parts.igem.org/Part:BBa_K1694037">BBa_K1694037</a></span><br>
 +
                                P<sub>cons</sub>+RBS+FadL-GBP+RBS+GFP+Ter<br>
 +
</td><td></td><td>With this part, we can test the GBP function by observing the green fluorescence on the gold chip. Terminator  is (<a href="http://parts.igem.org/Part:BBa_B0015">BBa_B0015</a>).
 +
</td></tr>
 +
 +
</table>
 
</div>
 
</div>
  
 +
</div>
 +
<div class="goto" style="background-color:#FCFCDE;">
 +
<a href="https://2015.igem.org/Team:NCTU_Formosa/Project"><img src="https://static.igem.org/mediawiki/2015/3/3c/%E7%AE%AD%E9%A0%AD1.png"; width=50vw;><br><br>Back to Navigation</a>
 +
</div>
 +
<div class="goto1" style="background-color:#FCFCDE;">
 +
<a href="https://2015.igem.org/Team:NCTU_Formosa/Practices"><img src="https://static.igem.org/mediawiki/2015/c/c2/%E7%AE%AD%E9%A0%AD2.png"; width=50vw;><br><br>Go to Practices</a>
 +
</div>
 +
 +
</body>
 
</html>
 
</html>
 +
 +
{{Team:NCTU_Formosa/footer}}

Latest revision as of 03:58, 19 September 2015

Composite Parts

Composite Part

BBa_K1694013
OmpA-anti-VEGF
BBa_K1694014
OmpA-anti-EGFR
BBa_K1694015
OmpA-anti-HER2
In order to change the scFv parts easily, we added a NcoI restriction site between OmpA and scFv so that we can change various scFv DNA sequence using the NcoI restriction enzyme.
BBa_K1694023
Pcons+RBS+OmpA-anti-VEGF
BBa_K1694024
Pcons+RBS+OmpA-anti-EGFR
BBa_K1694025
Pcons+RBS+OmpA-anti-HER2
By ligating the constitutive promoter (BBa_J23101), strong ribosome binding site (BBa_B0034) and Lpp-OmpA-scFv, we were able to display scFv on the E.coli outer membrane continuously. Having this part, we can co-transform with other parts in order to produce color as the detection signal.

In addition, by co-transforming these different types of E.coli with different fluorescence or color as signals, we are able to create a platform which can detect multimarker and consequently achieve combination therapy.
BBa_K1694033
Pcons+RBS+OmpA-anti-VEGF+RBS+GFP+Ter
BBa_K1694034
Pcons+RBS+OmpA-anti-EGFR+RBS+GFP+Ter
BBa_K1694035
Pcons+RBS+OmpA-anti-HER2+RBS+GFP+Ter
BBa_K1694044
Pcons+RBS+OmpA-anti-EGFR+RBS+RFP+Ter
BBa_K1694045
Pcons+RBS+OmpA-anti-HER2+RBS+BFP+Ter
The most commonly constructing way of composite parts is to ligate the required parts together. We also provide this kind of parts.
At the back of the Lpp-OmpA-scFv part, we ligated the weaker ribosome biding site (BBa_B0030), different fluorescent protein and terminator (BBa_J61048) to make it continuously and simultaneously express the fluorescence and the scFv. We used a weak ribosome binding site to ensure that scFv's production will not be affected.
BBa_K1694053
Pcons+RBS+OmpA-anti-VEGF+RBS+amilCP+Ter
BBa_K1694054
Pcons+RBS+OmpA-anti-EGFR+RBS+amilCP+Ter
BBa_K1694055
Pcons+RBS+OmpA-anti-HER2+RBS+amilCP+Ter
Chromoprotein is another example of what can be added when making your own probe.
We constructed this part as the Pcons+RBS+OmpA-scFv+RBS+fluorescent protein+Terminator part.
BBa_K1694027
Pcons+RBS+FadL-GBP
By ligating the induced promoter (BBa_J23110), ribosome binding site (BBa_B0034) and FadL-GBP, we can continuously display the GBP on the E.coli outer membrane.
Then we co-transform the OmpA-scFv parts and this FadL-GBP parts into the same E.coli, hence allowing our E.coli to bind on gold chips and detect antigens simultaneously.
BBa_K1694037
Pcons+RBS+FadL-GBP+RBS+GFP+Ter
With this part, we can test the GBP function by observing the green fluorescence on the gold chip. Terminator is (BBa_B0015).


Back to Navigation


Go to Practices